AMX-0114

N/A

Report date: 2025/06/04 17:18:29
NME

Base Information

Drug NameAMX-0114
Drug Alias NameAMX-0114
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCalpain-2 catalytic subunit inhibitors
TargetsCalpain-2 catalytic subunit
Therapy Area/IndicationsNeurodegenerative DiseasesAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmylyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmylyx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A